Form 4: Beauty Health CRO's Tax Withholding on RSU Vesting

The Beauty Health Company's Chief Revenue Officer, Ronald Menezes, reported the withholding of 61,471 shares for tax obligations related to restricted stock unit vesting.

Summary

• Ronald Menezes, Chief Revenue Officer of The Beauty Health Company (SKIN), reported a transaction on March 17, 2026.
• The transaction involved the disposition of 61,471 shares of Class A Common Stock.
• These shares were withheld by the issuer to satisfy tax withholding requirements upon the vesting of restricted stock units (RSUs), and do not represent a sale.
• The deemed price for these shares was $1.17 per share.
• Following this transaction, Menezes beneficially owns 1,013,234 shares of Class A Common Stock directly.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral event, as it represents a routine tax withholding related to executive compensation vesting, rather than a discretionary sale or purchase. The vesting itself is a positive for the executive.

Positives

• The vesting of restricted stock units indicates successful achievement of compensation milestones for the Chief Revenue Officer.
• The transaction is a non-discretionary tax withholding event, not a market sale by the officer, suggesting no change in personal investment sentiment.

Negatives

• The number of shares beneficially owned by the Chief Revenue Officer decreased by 61,471 due to tax withholding.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that routine Form 4 filings for tax withholdings on RSU vesting are common across industries, reflecting standard equity compensation practices for executives. This particular filing for The Beauty Health Co aligns with typical insider reporting for such events.

Comparison to Industry Standards

• The practice of withholding shares for tax purposes upon RSU vesting is a standard industry practice for equity compensation, observed across companies like Apple (AAPL), Microsoft (MSFT), and Amazon (AMZN) for their executives.
• The reported transaction is consistent with typical insider reporting requirements for executive compensation events.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine tax withholding, not a market sale. The underlying RSU vesting could be seen as a positive for executive retention and alignment of interests.
• Employees: Reflects standard executive compensation practices within the company.

Key Dates

Recommendation

This Form 4 filing details a routine tax withholding event related to the vesting of restricted stock units for a key executive. It does not indicate a discretionary sale or purchase based on new information, nor does it reveal any material changes to the company's operations or outlook. Therefore, it provides no new information that would warrant a change in an existing investment position.

Keywords

Beauty Health Co, SKIN, Ronald Menezes, Chief Revenue Officer, Form 4, Insider Transaction, Restricted Stock Units, Tax Withholding, Equity Compensation